Möchten Sie immer auf dem neuesten Stand bleiben?

Medtronic Launches Advisa DR MRI(TM) SureScan(TM) Pacing System in Japan MINNEAPOLIS - Oct. 18, 2012 - Medtronic, Inc. (NYSE: MDT), today announced the Japanese regulatory approval and launch of...

World's First Transcatheter Valve Honored as "Best Medical Technology" MINNEAPOLIS - October 17, 2012 - Medtronic, Inc.'s (NYSE: MDT) Melody® Transcatheter Pulmonary Valve was awarded the Prix...

Offering Surgeons in the United States a New Procedure to implant the BRYAN® Cervical Disc System MEMPHIS, TENN. - October 8, 2012 - Medtronic, Inc. (NYSE: MDT) today announced it has initiated the...

Largest Randomized Controlled Trial of Its Kind, IN.PACT DEEP Evaluates Safety and Effectiveness of Novel Treatment for Critical Limb Ischemia Below the Knee MINNEAPOLIS -- October 5, 2012 --...

Newly Approved Medical Device Expands Company's Growing Portfolio of Products Used to Treat Peripheral Artery Disease MINNEAPOLIS -- October 5, 2012 -- With a focus on developing lesion specific...

InSite Study Results Show Efficacy and Quality of Life Advantages with InterStim® System MINNEAPOLIS - October 4, 2012 - The first-ever study to compare the clinical benefits of Medtronic, Inc....

Strong Partnership in Promoting Healthy Lifestyles Continues for Three Additional Years MINNEAPOLIS - October 3, 2012 -Medtronic and Twin Cities In Motion, the organizers of the Medtronic Twin...

Multi-Electrode Radiofrequency Renal Denervation System Builds on Experience with the Symplicity(TM) Renal Denervation System  MINNEAPOLIS - October 3, 2012 - Medtronic, Inc. (NYSE: MDT) announced...

Medtronic Launches New European Clinical Study to Further Evaluate Direct Aortic Surgical Approach MINNEAPOLIS - October 2, 2012 - Medtronic, Inc. (NYSE: MDT) today reported two clinical research...

MINNEAPOLIS - October 1, 2012 - Medtronic, Inc., (NYSE: MDT), announced today the start of Symplicity HTN-Japan, the first clinical trial with the Symplicity(TM) renal denervation system in Japan...